Park Ha Biological Technology (BYAH) Receivables (2023 - 2026)

Park Ha Biological Technology (BYAH) has reported Receivables for 4 consecutive years, with -$3.4 million the latest figure, recorded in Q2 2026.

• Quarterly Receivables fell 425.06% year-over-year to -$3.4 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$3.4 million (down 425.06% YoY) and the FY2025 annual result came in at -$2.8 million, down 324.89% from the prior year.
• Receivables fell to -$3.4 million in Q2 2026 per BYAH's latest filing, from -$2.8 million in the prior quarter.
• Over the last five years, Receivables for BYAH reached as high as $1.0 million in Q2 2025 and fell as low as -$3.4 million in Q2 2026.
• A 4-year average of -$848395.0 and a median of $77070.0 in 2023 frame the typical range for Receivables.
• Annual changes were most pronounced in 2024 — Receivables jumped 958.06% — and 2025, when it slumped 440.69%.
• Year by year, Receivables stood at $77070.0 in 2023, then soared by 958.06% to $815446.0 in 2024, then sank by 440.69% to -$2.8 million in 2025, then fell by 22.5% to -$3.4 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered -$3.4 million, -$2.8 million, and $1.0 million for Q2 2026, Q4 2025, and Q2 2025 respectively.